These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1672641

  • 1. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
    Titus RG, Müller I, Kimsey P, Cerny A, Behin R, Zinkernagel RM, Louis JA.
    Eur J Immunol; 1991 Mar; 21(3):559-67. PubMed ID: 1672641
    [Abstract] [Full Text] [Related]

  • 2. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG, Lima GC, Engers HD, Louis JA.
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [Abstract] [Full Text] [Related]

  • 3. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C, Schröppel K, Lohoff M, Röllinghoff M, Solbach W.
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [Abstract] [Full Text] [Related]

  • 4. Adoptive transfer of delayed type hypersensitivity reactions specific for Leishmania major antigens to normal mice using murine T cell populations and clones generated in vitro.
    Lima GC, Engers HD, Louis JA.
    Clin Exp Immunol; 1984 Jul; 57(1):130-8. PubMed ID: 6204797
    [Abstract] [Full Text] [Related]

  • 5. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H, Scollay R.
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [Abstract] [Full Text] [Related]

  • 6. Generation of B cell memory and affinity maturation. Induction with Th1 and Th2 T cell clones.
    Rizzo LV, DeKruyff RH, Umetsu DT.
    J Immunol; 1992 Jun 15; 148(12):3733-9. PubMed ID: 1351086
    [Abstract] [Full Text] [Related]

  • 7. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties.
    Nagarkatti M, Clary SR, Nagarkatti PS.
    J Immunol; 1990 Jun 15; 144(12):4898-905. PubMed ID: 1972170
    [Abstract] [Full Text] [Related]

  • 8. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.
    Cell Immunol; 1996 May 25; 170(1):41-53. PubMed ID: 8660798
    [Abstract] [Full Text] [Related]

  • 9. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.
    Varkila K, Chatelain R, Leal LM, Coffman RL.
    Eur J Immunol; 1993 Jan 25; 23(1):262-8. PubMed ID: 8419179
    [Abstract] [Full Text] [Related]

  • 10. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 11. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 12. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P, Pearce E, Natovitz P, Sher A.
    J Immunol; 1987 Jul 01; 139(1):221-7. PubMed ID: 3495599
    [Abstract] [Full Text] [Related]

  • 13. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G.
    Eur J Immunol; 1996 Jul 01; 26(7):1553-9. PubMed ID: 8766560
    [Abstract] [Full Text] [Related]

  • 14. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.
    Cher DJ, Mosmann TR.
    J Immunol; 1987 Jun 01; 138(11):3688-94. PubMed ID: 2953788
    [Abstract] [Full Text] [Related]

  • 15. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.
    Holaday BJ, Sadick MD, Wang ZE, Reiner SL, Heinzel FP, Parslow TG, Locksley RM.
    J Immunol; 1991 Sep 01; 147(5):1653-8. PubMed ID: 1831830
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing the host response to Leishmania mexicana.
    Pérez H.
    Ciba Found Symp; 1983 Sep 01; 99():157-73. PubMed ID: 6227462
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan 01; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 18. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
    Morris L, Troutt AB, Handman E, Kelso A.
    J Immunol; 1992 Oct 15; 149(8):2715-21. PubMed ID: 1357029
    [Abstract] [Full Text] [Related]

  • 19. Notch1 expression on T cells is not required for CD4+ T helper differentiation.
    Tacchini-Cottier F, Allenbach C, Otten LA, Radtke F.
    Eur J Immunol; 2004 Jun 15; 34(6):1588-96. PubMed ID: 15162428
    [Abstract] [Full Text] [Related]

  • 20. Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3.
    Feng ZY, Louis J, Kindler V, Pedrazzini T, Eliason JF, Behin R, Vassalli P.
    Eur J Immunol; 1988 Aug 15; 18(8):1245-51. PubMed ID: 2970970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.